SCHEMBL2494232

SCHEMBL2494232

FC(F)(Br)C(F)(F)C(F)(F)Br

nearest known ligand 0.57

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL859731 0.89 LMNA (0.69) LMNA
SCHEMBL2721167 0.84 LMNA (0.77) LMNA
SCHEMBL2166117 0.84 LMNA (0.77) LMNA
SCHEMBL2721109 0.84 LMNA (0.77) LMNA
SCHEMBL2720797 0.80 LMNA (0.71) LMNA
SCHEMBL9527424 0.77 LMNA (0.67) LMNA
SCHEMBL537518 0.77 LMNA (0.92) LMNA
SCHEMBL159489 0.76
SCHEMBL16395226 0.74 LMNA (0.44) LMNA
Perflubron SCHEMBL8040555 0.74 LMNA (1.00) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 400 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119019689-A Novel functionalized high molecular polymer, preparation method thereof and electrolytic water composite diaphragm 国家电投集团科学技术研究院有限公司 2024-11-26 CN claimed
US-20260132282-A1 PRODUCTION METHOD OF MODIFIED POLYTETRAFLUOROETHYLENE AND COMPOSITION DAIKIN INDUSTRIES, LTD. (JP) 2026-05-14 US disclosed
US-12612477-B2 Method for producing fluoropolymer, polytetrafluoroethylene composition, and polytetrafluoroethylene powder DAIKIN INDUSTRIES, LTD. (JP) 2026-04-28 US disclosed
EP-4722290-A1 FLUORORUBBER COMPOSITION AND CROSSLINKED MOLDED OBJECT FORMED THEREFROM Zeon Corporation (JP) 2026-04-08 EP disclosed
US-20260085137-A1 METHOD FOR PRODUCING FLUOROPOLYMER AQUEOUS DISPERSION AND FLUOROPOLYMER AQUEOUS DISPERSION DAIKIN INDUSTRIES, LTD. (JP) 2026-03-26 US disclosed
EP-4715908-A1 BINDER FOR SOLID ELECTROLYTE BATTERY, SLURRY, ELECTRODE, AND SOLID ELECTROLYTE BATTERY Daikin Industries, Ltd. (JP) 2026-03-25 EP disclosed
EP-4715909-A1 BINDER FOR NONAQUEOUS ELECTROLYTE BATTERIES, ELECTRODE MIXTURE, ELECTRODE, AND NONAQUEOUS ELECTROLYTE BATTERY Daikin Industries, Ltd. (JP) 2026-03-25 EP disclosed
US-12583957-B2 Fluoropolymer-containing composition and molded article DAIKIN INDUSTRIES, LTD. (JP) 2026-03-24 US disclosed
US-12583947-B2 Method for producing fluoropolymer DAIKIN INDUSTRIES, LTD. (JP) 2026-03-24 US disclosed
EP-4711389-A1 METHOD FOR PRODUCING AQUEOUS FLUOROPOLYMER DISPERSION, AND AQUEOUS FLUOROPOLYMER DISPERSION Daikin Industries, Ltd. (JP) 2026-03-18 EP disclosed
EP-1494999-B1 OCCLUSIVE COMPOSITION COMPRISING A POLY(2-CYANOACRYLATE) MONOMER BOSTON SCIENT LTD (BB) 2006-06-07 EP disclosed
EP-1494999-A1 OCCLUSIVE COMPOSITION COMPRISING A POLY(2-CYANOACRYLATE) MONOMER Boston Scientific Limited (BB) 2005-01-12 EP disclosed
WO-2003087042-A1 OCCLUSIVE COMPOSITION COMPRISING A POLY (2-CYANOACRYLATE) MONOMER BOSTON SCIENTIFIC LIMITED (BB) 2003-10-23 WO disclosed
US-20030194389-A1 Occlusive composition STRYKER CORPORATION 2003-10-16 US disclosed
US-20020032292-A1 Fluoroelastomer and production thereof IKEDA SUNAO (JP) 2002-03-14 US disclosed
EP-0772575-B1 PREPARATION OF HALOGENATED COMPOUNDS DU PONT (US) 1998-09-30 EP disclosed
EP-0772575-A1 PREPARATION OF HALOGENATED COMPOUNDS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1997-05-14 EP disclosed
US-5504248-A Preparation of halogenated compounds E. I. DU PONT DE NEMOURS AND COMPANY (US) 1996-04-02 US disclosed
WO-1996003358-A1 PREPARATION OF HALOGENATED COMPOUNDS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1996-02-08 WO disclosed
US-5117055-A Method for direct conversion of fluorocarbonyl group into halogenides AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 1992-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030194389-A1 Occlusive composition C3AR1, F12, FGB LMNA 706/4885
US-20260132282-A1 PRODUCTION METHOD OF MODIFIED POLYTETRAFLUOROETHYLENE AND COMPOSITION F9, TAF9, AFF1 LMNA 1804/4885
US-20260085137-A1 METHOD FOR PRODUCING FLUOROPOLYMER AQUEOUS DISPERSION AND FLUOROPOLYMER AQUEOUS DISPERSION MTX1, MTX2, F11 LMNA 1474/4885
US-12583947-B2 Method for producing fluoropolymer SCO2, PYM1, POLM LMNA 2272/4885
US-12612477-B2 Method for producing fluoropolymer, polytetrafluoroethylene composition, and polytetrafluoroethylene powder CFAP410, CFAP20, PFN1 LMNA 4859/4885
US-12583957-B2 Fluoropolymer-containing composition and molded article AOC2, AOC1, AOC3 LMNA 639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.